4Chutima Pramoolsinsup . Management of viral hepatitis B. J Gastroenterol Hepatol, 2002, 2(17 ): 152- 162.
5Lau G K K , Tsiang M, Hou J , et al. Combinatinon therapy with lamwudine and famciclovir for chronic hepatitis B - infected Chirese patients: a viral dynamics study. Hepatology , 1999,32(2): 394 - 399.
6Schalm S W, Heathcote J , Cianciara J , et al. Lamivcldine and alpha interferon combination treatmeat of patients with chronic hepatitis B infection: a randonised trail. Gut ,2000,46(4) :562 - 568.
7Chaisomchit S, Tyrrell DL, Chang L J , et al . Development of replicative and nonreplicative hepatitis B virus vectors . Gene Ther , 1997,4(12): 1330 - 1340.
8Iu Putlitz J , Wieland S, Blum H E , et al . Antisense RNA Complementary to hepatitis B virus specifically inhibits viral replication . Gastroentrology, 1998,115(3) :702 - 713.
9Nako K , Nakata K , yamashita M , et al . ISGF - 3gmma is imolved in interferon - alpha induced suppressson of hepatitis B virus enhanceactivity J Biol chem, 1999,274(28) :28075 - 28078.
10Kweon yo , Goodman Z , DsenstagJL, etal . Decreasingfibrogenesis an immuno histochemical study of paired liver biopsies following lamivucline therapy for chronic hepatitis B. J Hepato , 2001,35:749.
